Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
CONDUCTION ABNORMALITIES IN ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY Stefan Peters - St.Elisabeth Hospital Salzgitter, Cardiology, Germany According to an article of Tabib et al., published in 2003, in more than 60% of cases fibrosis was found within structures of the conduction system of 200 autopsy cases with arrhythmogenic (right ventricular) cardiomyopathy-dysplasia (ARVC-D). The question is whether conduction abnormalities belong to the electrocardiographic spectrum of ARVC/D. Method: The very first ECG without medication was analysed with regard to conduction abnormalities (AV block 1° or 2° or 3°), right bundle branch block or need for pacemaker implantation of 376 patients with modified ISFC/ESC criteria of ARVC-D (210 males, mean age 46.4 ± 11.7 years). Results: Symptomatic AV block II° and III° were present in 6 patients and in additional 3 patients with provocable electrocardiographic Brugada pattern. A complete right bundle branch block as the initial electrocardiographic finding was found in 5 patients. Only nine patients presented with AV-block I°. The incidence of conduction abnormalities and complete right bundle branch block was only 6 %. Conclusions: The rate of fibrosis of the conduction system as described in the paper of Tabib cannot be confirmed, as the incidence of conduction abnormalities in only 6%. Fibrofatty changes of the conduction system were found in 7% of cases which correspond to the rate of conduction abnormalities. This finding can be seen in the light of rare non-desmosomal gene mutations encoding lamin A/C, titin, TMEM protein 43 and possibly cardiac sarcoidosis mimicking ARVC/D. Complete right bundle branch block is possibly the result of rare desmin gene mutations. AV block I° is more prevalent in Brugada syndrome and belongs to the electrocardiographic spectrum of this syndrome in SCN5A mutations.